DOCSLIB.ORG
  • Sign Up
  • Log In
  • Upload
  • Sign Up
  • Log In
  • Upload
  • Home
  • »  Tags
  • »  Stiripentol

Stiripentol

  • Stiripentol with an Average Age of 9.1 Years

    Stiripentol with an Average Age of 9.1 Years

  • 10|18 Stiripentol Use in Children with Refractory Seizures

    10|18 Stiripentol Use in Children with Refractory Seizures

  • Preferred Drug List 4-Tier

    Preferred Drug List 4-Tier

  • Audit of Use of Stiripentol in Adults with Dravet Syndrome

    Audit of Use of Stiripentol in Adults with Dravet Syndrome

  • Therapeutic Class Overview Anticonvulsants

    Therapeutic Class Overview Anticonvulsants

  • Primidone SERB 50Mg and 250Mg Tablets Primidone

    Primidone SERB 50Mg and 250Mg Tablets Primidone

  • Utah Medicaid Dur Report March 2019

    Utah Medicaid Dur Report March 2019

  • Stiripentol for Continuation in Adults with Dravet Syndrome (PDF)

    Stiripentol for Continuation in Adults with Dravet Syndrome (PDF)

  • New Antiepileptic Drugs

    New Antiepileptic Drugs

  • Diacomit, INN-Stiripentol

    Diacomit, INN-Stiripentol

  • Shared Care Guideline Stiripentol Use for SCN1A Related and Severe Myoclonic Epilepsies in Infancy

    Shared Care Guideline Stiripentol Use for SCN1A Related and Severe Myoclonic Epilepsies in Infancy

  • Pharmaceuticals and Medical Devices Safety Information No

    Pharmaceuticals and Medical Devices Safety Information No

  • PDL)/Non-Preferred Drug List (NPDL

    PDL)/Non-Preferred Drug List (NPDL

  • Product Monograph Diacomit

    Product Monograph Diacomit

  • Novel Antiepileptic Drugs

    Novel Antiepileptic Drugs

  • Medicaid List of Covered Drugs (Formulary)

    Medicaid List of Covered Drugs (Formulary)

  • Diacomit® (Stiripentol Capsules and Powder for Oral Suspension)

    Diacomit® (Stiripentol Capsules and Powder for Oral Suspension)

  • Stiripentol in Dravet Syndrome: Results of a Retrospective U.S. Study *Elaine C

    Stiripentol in Dravet Syndrome: Results of a Retrospective U.S. Study *Elaine C

Top View
  • DIACOMIT (Stiripentol)
  • CDR Clinical Review Report on Diacomit (Stiripentol)
  • Fenfluramine for Treatment-Resistant Seizures in Patients with Dravet Syndrome Receiving Stiripentol-Inclusive Regimens a Randomized Clinical Trial
  • Diacomit 100 Mg Hard Capsules
  • Efficacy of Stiripentol in Dravet Syndrome with Or Without SCN1A Mutations
  • Drug Benefit Guide
  • Product Monograph DIACOMIT® (Stiripentol) in the Treatment of Seizures Associated with Dravet Syndrome in Patients 2 Years of Age and Older Taking Clobazam
  • Medicare Model Guidelines Draft V8.0 1 of 97
  • Diacomit, INN: Stiripentol
  • DIACOMIT® (Stiripentol) Drug Interactions DIACOMIT® (Stiripentol) Drug Interactions
  • Wo 2007/044693 A2
  • DIACOMIT (Stiripentol) RATIONALE for INCLUSION in PA PROGRAM
  • Therapeutic Class Overview Anticonvulsants
  • Newer Anti-Epileptic Drugs
  • Application Number
  • An Updated Overview on Therapeutic Drug Monitoring of Recent Antiepileptic Drugs
  • January February 2019 Clinical Rx Forum Newsletter.Pub
  • Stiripentol (Diacomit®) EOCCO POLICY


© 2024 Docslib.org    Feedback